Walleye Trading
AKCA

Walleye Trading’s Akcea Therapeutics Inc AKCA Stock Holding History

Walleye Trading’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-7,600
Closed -$215K – 4728
2019
Q1 		$215K Buy
+7,600
New +$221K ﹤0.01% 2966
2018
Q4 		– Sell
-6,500
Closed -$228K – 5641
2018
Q3 		$228K Buy
+6,500
New +$197K ﹤0.01% 3654

Other funds holding AKCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Walleye Trading's AKCA Position: Q2 2019 in Review

Walleye Trading sold out of Akcea Therapeutics Inc (AKCA) in Q2 2019, closing a stake of 3,021 shares — an estimated $86K sold.

Walleye Trading first reported a position in AKCA in Q1 2019 and held it in 1 quarter. The position peaked at $86K in Q1 2019. 68 funds tracked by Wall St. Rank hold AKCA as of Q2 2019.

  • Walleye Trading reported no remaining Akcea Therapeutics Inc position as of Q2 2019 after selling out during the quarter.
  • Walleye Trading sold 3,021 Akcea Therapeutics Inc shares in Q2 2019, an estimated $86K.
  • Walleye Trading first reported a position in Akcea Therapeutics Inc in Q1 2019 and held it in 1 quarter.
  • Walleye Trading's Akcea Therapeutics Inc position peaked at $86K in Q1 2019.
  • 68 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q2 2019.

Based on Walleye Trading's 13F filing for Q2 2019, filed 14 Aug 2019.